Go Back Go Back
Go Back Go Back
Go Back Go Back

Tender for medical supplies

Tender for medical supplies

2024-07-09

Download Icon

Goods should be provided on a DAP (Kyiv, Ukraine) basis.
If you are interested in submitting a bid for these items/services, kindly fill in the attached
submission form and send it to the secure email address indicated below/ not later than 9th of July 2024 at 12:00 (Kyiv Time).

Please ensure to mark your email with the ITB reference number and the words “Sealed bid”. Do
not open before the 9th of July 2024 at 12:00 (Kyiv Time).

Secure email address for bid submission ua-procurement@unfpa.org.
Note: Do not submit your bid/proposal to the contact person’s email address!

Please submit your quotation in USD currency. Conversion of currency into the UNFPA preferred
currency, if the offer is quoted differently from what is required, shall be based only on the UN
Operational Exchange Rate prevailing at the time of the competition deadline.

In case of technical questions, please write to the following emails:
Andrii Seredenko, seredenko@unfpa.org
Maryna Nikolaienko, nikolaienko@unfpa.org

Bidding shall be conducted through ONE envelope. The technical bid containing the technical
specifications and the financial bid containing the price information shall be submitted together
.

Documents to be submitted with the bid:
a. Completed and signed Bid Submission Form (Annex 1)
b. Bidders Identification Form (Annex 2)
c. Product item overview (Annex 3)
d. Technical bid, including:

 The manufacturer and the trade name for each item/medicine with full info
on the ingredients.
 Picture/photo of the finished pharmaceutical product and labeling.
 Packaging details

e. Financial bid including the price schedule. (Annex 4)
f. FTP Questionnaire for Pharmaceuticals (Annex 5)
g. Approval letter or certificate from the national Ukrainian regulatory body which confirms
local registration of the product and permission to use in medical practice in Ukraine.
h. GMP certificate for Finished Pharmaceutical Product (FPP) manufacturer.
i. Certificate of analysis for at least one recently released batch.
j. Package insert if applicable and patient information leaflet (PIL).
k. Signed declaration that the product to be supplied meets the locally approved.

Partial bids are not allowed under this ITB.

INCOTERMS 2010:
Price of goods should include the delivery on a DAP (Kyiv, Ukraine) basis.

Validity of Bid:
The prices of the bid shall be valid for 90 days after the closing date of bid submission as specified
by UNFPA. A bid valid for a shorter period shall be rejected by UNFPA.

Delivery Time:
The maximum allowed delivery time is 60 days upon issuing of purchase order.
All items are subject to pre-shipment inspection as requested by UNFPA CO Ukraine.

Evaluation of Bids:
UNFPA shall compare all substantially responsive bids to determine the lowest-priced
substantially responsive bid.
A substantially responsive bid is one that conforms to all the terms, conditions, and specifications
of the bidding documents without material deviation, reservation, or omission. A material
deviation, reservation, or omission is one that:
a. affects in any substantial way the scope, quality, or performance of the goods and related
services specified in the contract; or
b. limits in any substantial way, inconsistent with the bidding documents, UNFPA’s rights or
the bidder’s obligations under the contract; or
c. if rectified would unfairly affect the competitive position of other bidders presenting
substantially responsive bids.

Contract Award:
UNFPA shall award the contract to the lowest priced bidder(s) whose bid has been
determined to be substantially responsive to the bidding documents, including the
maximum allowable lead time, and full acceptance of the UNFPA General Terms and
Conditions.

Note: Current UNFPA supplier policies apply to this solicitation and can be found
at: http://www.unfpa.org/suppliers.

UNFPA reserves the right to increase or decrease the quantity of the order given in
this request for proposals, without changing the price per unit of the product or
other conditions.

Attachments:
- Bid Submission Form (Annex -1)
- Bidders Identification Form (Annex -2)
- Technical specification and requirements of the product (Product Item Overview
Form) (Annex -3)
- Price Schedule Form (Annex -4)
- FTP Questionnaire for Medical Devices (Annex -5)



We undertake, if our bid/proposal is accepted, to commence and complete delivery of all
items in the contract within the time frame stipulated.

We understand that you are not bound to accept any bid you may receive and that a
bidding contract would result only after final negotiations are concluded on the basis of
the technical and price bids proposed.

Annex 2 - Bidders Identification Form 

1) Organization 

Company/Institution Name
Address, City, Country
Telephone/FAX
Website
Date of establishment
Legal Representative:
Name/Surname/Position
Legal structure: natural person/Co. Ltd,
NGO/institution/other (please specify)
Organizational Type: Manufacturer,
Wholesaler, Trader, Service provider, etc.
Areas of expertise of the organization
Current Licenses, if any, and permits (with
dates, numbers and expiration dates)
Years supplying to UN organizations
Years supplying to UNFPA
Production Capacity
Subsidiaries in the region (please indicate
names of subsidiaries and addresses, if
relevant to the bid)
Commercial Representatives in the country:
Name/Address/Phone (for international
companies only)

2) Quality assurance certification

International Quality Management System
(QMS)
List of other ISO certificates or equivalent
certificates
Presence and characteristics of in-house quality
control laboratory (if relevant to bid)

3) Expertise of stuff

Total number of staff
Number of staff involved in similar supply
contracts

4) Client reference list

Please provide references of main client details.

Name of company

Contact person

Telephone

E-mail

5) Contact details of persons that UNFPA may contact for requests for clarification during
bid evaluation.

Name/Surname
Telephone Number
(direct)
Email address (direct)

P.S.: This person must be available during the next two weeks following receipt of the bid.

Annex 3 - Product Item Overview Form

Item No. Description and minimum
/mandatory specifications
Description of items offered
and Bidder’s statements on
deviations

(To be completed by the
bidder)
Compliant
? (Y/N)

(To be
completed
by UNFPA
during
evaluation)
1 Poractant Alfa: Intratracheal
Suspension, – vial, 1.5 mL [120 mg
surfactant extract]
   
2 Caffeine Citrate: 20 mg/ml solution for
infusion and oral solution
   

Annex 4 - Price Schedule Form

Name of Bidder: ___
Date of Bid: ____
Bid No: ____
Currency of Bid price: USD
Delivery time (days from receipt of order till dispatch): ___
(Note: maximum number of days is: 60 days) ___
Expiration of Validity of Bid/Proposal (The bid shall be
valid for a period of at least 90 days after the Closing date.): ___

Item No. Quantity Unit Price (USD) Total Price (USD) DAP Kyiv Delivery schedule (days upon order)
1.        
2.        
 
PROVIDED THAT A PURCHASE ORDER IS ISSUED BY UNFPA WITHIN THE REQUIRED
BID VALIDITY PERIOD
, THE UNDERSIGNED HEREBY COMMITS, SUBJECT TO THE
TERMS OF SUCH PURCHASE ORDER, TO FURNISH ANY OR ALL ITEMS AT THE PRICES
OFFERED AND TO DELIVER SAME TO THE DESIGNATED POINT(S) WITHIN THE
DELIVERY TIME STATED ABOVE.

Annex 5 - UNFPA Questionnaire for
Pharmaceutical Products under FTP

Please complete all the fields in the questionnaire as required and attach the requested supporting
documents. Please fill out one form separately for each pharmaceutical product.

1) MANUFACTURER DETAILS

Name of manufacturer:      
Physical address (include Block number, line number, etc.):
Postal address:      
City:       Country:      
Telephone:       Fax:      
E-mail:       Website:     


A. Include a copy of the registration certificate or evidence that the product is registered in the
country of intended use.

2) FINISHED DRUG PRODUCT

2.1. IDENTIFICATION

Content Active Pharmaceutical Ingredient Amount in dosage form or
amount per unit (Strength)
Active Ingredient 1    
Active Ingredient 2 (if
applicable)
   

Inactive Ingredients (excipients) of medical/pharmaceutical relevance (e.g. sugar, allergens such as
preservatives, lactose) amount in dosage form or per dosage unit (e.g. Contains Alcohol 10%):
     
Brand/trade name (if any):      
Dosage form (select below):
□ Tablets
o Uncoated
o Sugar coated
o Film coated
o Enteric coated
□ Capsules
□ Syrup/oral liquids
□ Injection
o Microcrystalline
suspension
o Oily solution
o Aqueous solution

o Powder for injection
□ Implants

Route of administration (select below):

 Oral

 I.M.

 I.V.

 S.C.

 Other (Please
specify)

2.2 PACKAGING
Number of dosage units per unit packs:      
Description of primary packaging materials:      
B. Attach package insert and/or patient information leaflet (PIL).
C. Picture/photo of the finished pharmaceutical product and labelling.
D. Certificate of analysis for at least one recently released batch (not more than 1 year old).

2.3 SHELF LIFE and STORAGE CONDITIONS
Shelf life as it appears on the packaging:      
Temperature:      
Light:      
Humidity:      
Other (Specify):      

2.4. REGULATORY STATUS

  • Registration Number of Pharmaceutical Product:
  • Valid until:
  • Regulatory issued by (Name of Agency):
  • Country:
  • Valid GMP certificate for Finished Pharmaceutical Products (FPP).

3) DECLARATION BY BIDDER/MANUFACTURER

F. Filled out declaration from bidder/manufacturer.

[Company letterhead]

Declaration by bidder/manufacturer

I, the undersigned certify that all the information in this declaration and all accompanying
documentation is correct and updated. I further certify that I have examined the following
statements and I attest to their accuracy.

1. The holder of the national registration follows national requirements for handling adverse
reaction on its products.
2. The holder of the national registration follows national requirements for handling batch
recalls of its products.
3. The formula to be supplied is exactly the same as the formula approved by National
Regulatory Authority (NRA), ………… (insert name of NRA). The strength, specifications (API,
excipients and FPP), etc. are exactly the same as the formula approved NRA.
4. The primary packaging is exactly the same in all aspects, including specifications, as the
primary packaging approved for use in the same product as approved by the NRA .
5. The secondary packaging is exactly the same in all aspects, including specifications, as the
primary packaging approved for use in the same product as approved by the NRA.
6. The information in the questionnaire/dossier submitted to UNFPA contains information
which is the same as the information in the dossier which is approved by the NRA.
7. The package insert, summary of product characteristics, patient information leaflet
submitted in the submission are the same as those approved by the NRA.
8. Where there are any differences in any aspect of the product including formula,
manufacturing site of API, manufacturing site of FPP, specifications of primary packaging,
specifications of secondary packaging, package insert, summary of product characteristics,
patient information leaflet, I have stipulated these and the justification for the changes in a
separate document and submitted to UNFPA.

 

  • Name:
  • Signature:
  • Position in Company:
  • Date:
Annex: Checklist of attachments required

Please ensure that all documents necessary to enable objective evaluation of your product are attached.
This checklist may not be exhaustive.
☐ A. Copy of the registration certificate or evidence that the product is registered in the country of
intended use.
☐ B. Package insert and patient information leaflet (PIL).
☐ C. Picture/photo of the finished pharmaceutical product and labelling.
☐ D. Certificate of analysis for at least one recently released batch (not more than 1 year old).
☐ E. Valid GMP certificate for Finished Pharmaceutical Product (FFP).
☐ F. Filled out declaration from bidder/manufacturer.